agilon health, inc.
AGL
$0.43
-$0.01-2.43%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.92B | 5.87B | 5.89B | 5.98B | 6.05B |
| Total Other Revenue | 11.24M | 11.97M | 12.32M | 12.56M | 12.82M |
| Total Revenue | 5.93B | 5.89B | 5.90B | 5.99B | 6.06B |
| Cost of Revenue | 6.09B | 5.99B | 6.01B | 6.01B | 6.06B |
| Gross Profit | -160.02M | -107.61M | -104.13M | -19.53M | 4.84M |
| SG&A Expenses | 232.46M | 233.61M | 243.18M | 255.76M | 264.34M |
| Depreciation & Amortization | 28.59M | 28.12M | 26.91M | 25.50M | 24.46M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.35B | 6.25B | 6.28B | 6.29B | 6.34B |
| Operating Income | -421.08M | -369.34M | -374.21M | -300.78M | -283.96M |
| Income Before Tax | -404.10M | -321.21M | -327.70M | -253.63M | -248.83M |
| Income Tax Expenses | 1.25M | 1.68M | 1.43M | 1.78M | 1.45M |
| Earnings from Continuing Operations | -405.35 | -322.90 | -329.12 | -255.41 | -250.28 |
| Earnings from Discontinued Operations | 14.00M | 14.64M | 13.46M | 13.46M | -9.82M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | 0.00 | -20.00K | -50.00K |
| Net Income | -391.35M | -308.26M | -315.66M | -241.98M | -260.15M |
| EBIT | -421.08M | -369.34M | -374.21M | -300.78M | -283.96M |
| EBITDA | -395.73M | -341.22M | -347.30M | -275.28M | -259.49M |
| EPS Basic | -0.94 | -0.75 | -0.77 | -0.59 | -0.63 |
| Normalized Basic EPS | -0.55 | -0.47 | -0.49 | -0.38 | -0.37 |
| EPS Diluted | -0.94 | -0.75 | -0.77 | -0.59 | -0.63 |
| Normalized Diluted EPS | -0.55 | -0.47 | -0.49 | -0.38 | -0.37 |
| Average Basic Shares Outstanding | 1.66B | 1.65B | 1.65B | 1.65B | 1.64B |
| Average Diluted Shares Outstanding | 1.66B | 1.65B | 1.65B | 1.65B | 1.64B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |